Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

IMPORTANCE: Postmarket safety events of novel pharmaceuticals and biologics occur when new safety risks are identified after initial regulatory approval of these therapeutics. These safety events can change how novel therapeutics are used in clinical practice and inform patient and clinician decisio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Downing, Nicholas S., Shah, Nilay D., Aminawung, Jenerius A., Pease, Alison M., Zeitoun, Jean-David, Krumholz, Harlan M., Ross, Joseph S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2017
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5815036/
https://ncbi.nlm.nih.gov/pubmed/28492899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2017.5150
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados